Schedule 13G ownership disclosure

CLEARMIND MEDICINE INC

Common Stock, no par value · CUSIP: 185053402

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Iroquois Capital Management, LLC

    Shares: 250,267.00 · Class: 4.99%

  • Richard Abbe

    Shares: 451,685.00 · Class: 6.24%

  • Kimberly Page

    Shares: 250,267.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-25-000588
Form type
SCHEDULE 13G/A
Filer
Clearmind Medicine Inc.
CIK
CIK 1892500
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub